
In this video exclusive, Aasma Shaukat, MD, MPH, professor at NYU Grossman School of Medicine, discusses how her group achieved diverse enrollment for PREEMPT CRC, a study designed to validate a blood test for colorectal cancer screening.
“In this trial, we were able to enroll a much higher proportion of both Blacks and Hispanics than traditionally in clinical trials and also much higher than representation in the U.S. population,” Shaukat, who also is co-lead and co-principal investigator for the Prevention of Colorectal Cancer Through Multiomics Blood Testing (PREEMPT CRC) trial,